Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Plan B Investigation May Get No HELP In Senate

This article was originally published in The Tan Sheet

Executive Summary

FDA's handling of an emergency contraception switch may be less likely to come under investigation with new leadership on the Senate HELP committee

You may also be interested in...

FDA Comes Under Fire From Sen. Clinton Over Plan B Decision

Sen. Hillary Clinton (D-N.Y.) is calling for a hearing and separate GAO investigation into FDA's decision to deny OTC approval of Barr's Plan B (levenorgestrel) emergency contraceptive

Henney Nomination Moves To "Enzi" Game; Floor Time Is Last Hurdle

The confirmation process for FDA Commissioner-nominee Jane Henney, MD, is in the hands of the Senate leadership after the Senate Labor & Human Resources Committee voted in favor of the nomination Sept. 23.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts